about
Prolyl hydroxylase 2 dependent and Von-Hippel-Lindau independent degradation of Hypoxia-inducible factor 1 and 2 alpha by selenium in clear cell renal cell carcinoma leads to tumor growth inhibitionHIF1α and HIF2α: sibling rivalry in hypoxic tumour growth and progressionThermal unfolding pathway of PHD2 catalytic domain in three different PHD2 species: computational approachesProlyl hydroxylase domain 2 protein is a strong prognostic marker in human gastric cancerHIF prolyl hydroxylase inhibitors for anemiaSubcellular Energetics and Metabolism: Potential Therapeutic Applications.Antiangiogenic activity of phthalides-enriched Angelica Sinensis extract by suppressing WSB-1/pVHL/HIF-1α/VEGF signaling in bladder cancer.Overexpression of the HIF hydroxylases PHD1, PHD2, PHD3 and FIH are individually and collectively unfavorable prognosticators for NSCLC survivalImmunohistochemical analysis of the mechanistic target of rapamycin and hypoxia signalling pathways in basal cell carcinoma and trichoepithelioma.Suppression of glioma progression by Egln3Low Molecular Weight Fucoidan Inhibits Tumor Angiogenesis through Downregulation of HIF-1/VEGF Signaling under Hypoxia.Cnidium officinale extract and butylidenephthalide inhibits retinal neovascularization in vitro and in vivoPotential regulation of glioma through the induction of apoptosis signaling via Egl-9 family hypoxia-inducible factor 3Glioblastoma angiogenesis: VEGF resistance solutions and new strategies based on molecular mechanisms of tumor vessel formation.Endothelial cell metabolism and tumour angiogenesis: glucose and glutamine as essential fuels and lactate as the driving force.Radiobiological modifiers in clinical radiation oncology: current reality and future potential.A positive feedback loop promotes HIF-1α stability through miR-210-mediated suppression of RUNX3 in paraquat-induced EMT.Hypoxia-driven osteopontin contributes to breast tumor growth through modulation of HIF1α-mediated VEGF-dependent angiogenesis.Constitutive expression of HIF-α plays a major role in generation of clear-cell phenotype in human primary and metastatic renal carcinoma.A hidden aggregation-prone structure in the heart of hypoxia inducible factor prolyl hydroxylase.Hypoxia inducible factor (HIF) in the tumor microenvironment: friend or foe?Expression of hypoxia-inducible factor-1α, vascular endothelial growth factor and prolyl hydroxylase domain protein 2 in cutaneous squamous cell carcinoma and precursor lesions and their relationship with histological stages and clinical features.
P2860
Q21261281-0B12417B-C7A5-4150-A3CD-0859958E7901Q27025886-2E289048-073F-4984-9695-AEDBA149E9E0Q27315139-2781D3DD-8988-419C-AAB1-41E81C725F87Q28257189-B3EEBDB6-E98E-4B10-9F54-47AD753085E0Q28307377-BE622099-1800-4576-9AEB-E80FA41EED9AQ30253000-38BAAD21-242A-4E6F-BC33-15080EE7AA58Q33906104-37F1E77F-F906-40FA-97D6-F69EF90B1E7EQ34009639-401FDEDD-AEDE-408D-A03D-03C05B8C44A8Q34122334-53784EE7-F11B-4A7E-A831-F20818367551Q34384193-A9B791E8-C4DC-4036-B975-347CF7F342CCQ35890752-79087CA6-A624-4275-B7BD-BD6E16796CE4Q36082268-0BD081CF-4E4E-4D19-81F9-6B3996AB12FCQ37700702-EC5C11C6-6D0F-4DC7-86F1-5567EF40E5EDQ37973261-AA5238F2-4167-4D33-BC38-CC5584F2D6E3Q38065324-DCE29601-1C71-4DD7-A91A-80BBA52A293FQ38294597-C61CABBA-213C-4504-BD0D-5A1093F6382CQ38658747-010B1488-0E43-464F-A9C0-7DD9C1237678Q39144797-F464A02A-3DA7-4462-BD76-29B7210EBDE0Q42928626-0BD2B5E1-DA6D-400C-878C-F6E6CFBB8491Q46597277-06C6C907-20B0-4D62-97C7-92EB0033F00AQ47893488-31BE193F-4C1B-431B-A9F8-C02EAE908494Q54417791-7AC46C88-A0D5-465F-81B3-CB42A62A8ACC
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 11 May 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
PHD2 in tumour angiogenesis.
@en
PHD2 in tumour angiogenesis.
@nl
type
label
PHD2 in tumour angiogenesis.
@en
PHD2 in tumour angiogenesis.
@nl
prefLabel
PHD2 in tumour angiogenesis.
@en
PHD2 in tumour angiogenesis.
@nl
P2860
P356
P1476
PHD2 in tumour angiogenesis.
@en
P2093
P2860
P2888
P356
10.1038/SJ.BJC.6605682
P407
P577
2010-05-11T00:00:00Z
2010-06-29T00:00:00Z